Reportlinker Adds Asia-Pacific Neurology Devices Market Outlook to 2017
NEW YORK, April 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Asia-Pacific Neurology Devices Market Outlook to 2017
http://www.reportlinker.com/p0336615/Asia-Pacific-Neurology-Devices-Market-Outlook-to-2017.html
Asia-Pacific Neurology Devices Market Outlook to 2017
Summary
GlobalData's new report, "Asia-Pacific Neurology Devices Market Outlook to 2017" provides key market data on the Asia-Pacific Neurology Devices market – China, Australia, India, and Japan. The report provides value (USD million) data for all the market categories – Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and CSF Management. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Countries covered include China, India, Australia and Japan.
- Market size and company share data for Neurology Devices market categories – Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products,Radiosurgery and CSF Management.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the Asia-Pacific Neurology Devices market..
- Key players covered include Medtronic, Inc., Terumo Corporation, Boston Scientific Corporation, Nihon Kohden Corporation, Elekta AB, DePuy, Inc. and others
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Asia-Pacific Neurology Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What is This Report About? 11
3 Neurology Devices in Asia-Pacific 12
3.1 Neurology Devices Cross Country Comparison, Revenue ($m), 2003-2017 12
3.2 Neurology Devices, Asia-Pacific, Overall Revenue ($m), 2003-2017 13
3.3 Neurology Devices, Asia-Pacific, Category Volume (Units), 2003-2017 20
3.4 Neurology Devices, Asia-Pacific, Company share (2009-2010) 25
4 Neurology Devices In Japan 27
4.1 Neurology Devices, Japan, Overall Revenue ($m), 2003-2017 27
4.2 Neurology Devices, Japan, Category Volume (Units), 2003-2017 33
4.3 Neurology Devices, Japan, Distribution Share (2009-2010) 38
4.3.1 CSF Management Japan, Distribution Share (2009-2010) 38
4.3.2 Interventional Neurology Japan, Distribution Share (2009-2010) 38
4.3.3 Neurological Diagnostic Equipment Japan, Distribution Share (2009-2010) 39
4.3.4 Neurostimulation Devices Japan, Distribution Share (2009-2010) 39
4.3.5 Neurosurgical Products Japan, Distribution Share (2009-2010) 40
4.3.6 Radiosurgery Japan, Distribution Share (2009-2010) 40
4.4 Neurology Devices, Japan, Company Share (2009-2010) 41
4.4.1 Neurology Devices, Japan, Company Share (2009-2010) 41
4.4.2 CSF Management, Japan, Company Share (2009-2010) 43
4.4.3 Interventional Neurology, Japan, Company Share (2009-2010) 44
4.4.4 Neurological Diagnostic Equipment, Japan, Company Share (2009-2010) 46
4.4.5 Neurostimulation Devices, Japan, Company Share (2009-2010) 47
4.4.6 Neurosurgical Products, Japan, Company Share (2009-2010) 48
4.4.7 Radiosurgery, Japan, Company Share (2009-2010) 49
5 Neurology Devices In Australia 50
5.1 Neurology Devices, Australia, Overall Revenue ($m), 2003-2017 50
5.2 Neurology Devices, Australia, Category Volume (Units), 2003-2017 56
5.3 Neurology Devices, Australia, Distribution Share (2009-2010) 61
5.3.1 CSF Management, Australia, Distribution Share (2009-2010) 61
5.3.2 Interventional Neurology, Australia, Distribution Share (2009-2010) 61
5.3.3 Neurological Diagnostic Equipment, Australia, Distribution Share (2009-2010) 62
5.3.4 Neurostimulation Devices, Australia, Distribution Share (2009-2010) 62
5.3.5 Neurosurgical Products, Australia, Distribution Share (2009-2010) 63
5.3.6 Radiosurgery Australia, Distribution Share (2009-2010) 63
5.4 Neurology Devices, Australia, Company Share (2009-2010) 64
5.4.1 Neurology Devices, Australia, Company Share (2009-2010) 64
5.4.2 CSF Management, Australia, Company Share (2009-2010) 66
5.4.3 Interventional Neurology, Australia, Company Share (2009-2010) 68
5.4.4 Neurological Diagnostic Equipment, Australia, Company Share (2009-2010) 70
5.4.5 Neurostimulation Devices, Australia, Company Share (2009-2010) 72
5.4.6 Neurosurgical Products, Australia, Company Share (2009-2010) 74
5.4.7 Radiosurgery, Australia, Company Share (2010) 75
6 Neurology Devices In China 76
6.1 Neurology Devices, China, Overall Revenue ($m), 2003-2017 76
6.2 Neurology Devices, China, Category Volume (Units), 2003-2017 82
6.3 Neurology Devices, China, Distribution Share (2009-2010) 87
6.3.1 CSF Management China, Distribution Share (2009-2010) 87
6.3.2 Interventional Neurology China, Distribution Share (2009-2010) 87
6.3.3 Neurological Diagnostic Equipment China, Distribution Share (2009-2010) 88
6.3.4 Neurostimulation Devices China, Distribution Share (2009-2010) 88
6.3.5 Neurosurgical Products China, Distribution Share (2009-2010) 89
6.4 Neurology Devices, China, Company Share (2009-2010) 90
6.4.1 Neurology Devices, China, Company Share (2009-2010) 90
6.4.2 CSF Management, China, Company Share (2009-2010) 92
6.4.3 Interventional Neurology, China, Company Share (2009-2010) 94
6.4.4 Neurological Diagnostic Equipment, China, Company Share (2009-2010) 96
6.4.5 Neurostimulation Devices, China, Company Share (2009-2010) 97
6.4.6 Neurosurgical Products, China, Company Share (2009-2010) 98
7 Neurology Devices In India 99
7.1 Neurology Devices, India, Overall Revenue ($m), 2003-2017 99
7.2 Neurology Devices, India, Category Volume (Units), 2003-2017 105
7.3 Neurology Devices, India, Distribution Share (2009-2010) 110
7.3.1 CSF Management, India, Distribution Share 110
7.3.2 Interventional Neurology, India, Distribution Share 110
7.3.3 Neurological Diagnostic Equipment, India, Distribution Share 111
7.3.4 Neurostimulation Devices, India, Distribution Share 111
7.3.5 Neurosurgical Products, India, Distribution Share 112
7.3.6 Radiosurgery, India, Distribution Share 112
7.4 Neurology Devices, India, Company Share (2009-2010) 113
7.4.1 Neurology Devices, India, Company Share (2009-2010) 113
7.4.2 CSF Management, India, Company Share (2009-2010) 115
7.4.3 Interventional Neurology, India, Company Share (2009-2010) 116
7.4.4 Neurological Diagnostic Equipment, India, Company Share (2009-2010) 118
7.4.5 Neurostimulation Devices, India, Company Share (2009-2010) 119
7.4.6 Neurosurgical Products, India, Company Share (2009-2010) 120
7.4.7 Radiosurgery, India, Company Share (2009-2010) 122
8 Overview of Key Companies in Asia-Pacific Neurology Devices Market 123
8.1 Medtronic, Inc. 123
8.1.1 Company Overview 123
8.1.2 Share in the Asia-Pacific Neurology Devices Market 123
8.2 Terumo Corporation 124
8.2.1 Company Overview 124
8.2.2 Share in the Asia-Pacific Neurology Devices Market 124
8.3 Boston Scientific Corporation 125
8.3.1 Company Overview 125
8.3.2 Share in the Asia-Pacific Neurology Devices Market 125
8.4 Nihon Kohden Corporation 126
8.4.1 Company Overview 126
8.4.2 Share in the Asia-Pacific Neurology Devices Market 127
8.5 Elekta AB 128
8.5.1 Company Overview 128
8.5.2 Share in the Asia-Pacific Neurology Devices Market 128
8.6 DePuy, Inc. 129
8.6.1 Company Overview 129
8.6.2 Share in the Asia-Pacific Neurology Devices Market 129
8.7 St. Jude Medical, Inc. 130
8.7.1 Company Overview 130
8.8 Covidien plc 130
8.8.1 Company Overview 130
8.9 B. Braun Melsungen AG 131
8.9.1 Company Overview 131
8.10 Micrus Endovascular Corporation 131
8.10.1 Company Overview 131
8.11 Integra LifeSciences Holdings Corporation 131
8.11.1 Company Overview 131
8.12 Cadwell Laboratories, Inc. 132
8.12.1 Company Overview 132
8.13 ev3 Inc. 132
8.13.1 Company Overview 132
8.14 CareFusion Corporation 132
8.14.1 Company Overview 132
8.15 Accuray Incorporated 133
8.15.1 Company Overview 133
8.16 Cyberonics, Inc. 133
8.16.1 Company Overview 133
8.17 Mizuho Ikakogyo Co., Ltd. 133
8.17.1 Company Overview 133
8.18 Natus Medical Incorporated 134
8.18.1 Company Overview 134
8.19 Sophysa S.A. 134
8.19.1 Company Overview 134
8.20 KARL STORZ GmbH & Co. KG 134
8.20.1 Company Overview 134
8.21 Micromed S.p.A 135
8.21.1 Company Overview 135
9 Neurology Devices Market Pipeline Products 136
10 Recent Developments 140
10.1 Strategy and Business Planning 140
10.1.1 Mar 21, 2011: St. Jude Medical Opens Technology Center For Physicians In Beijing, China 140
10.1.2 Mar 09, 2011: Medtronic Inaugurates New Manufacturing Facility In Singapore 140
10.1.3 Sep 02, 2010: Elekta Opens South Korean Office 141
10.1.4 Aug 08, 2010: Medtronic Opens Patient Care Center In Beijing, China 142
10.1.5 Mar 24, 2010: Accuray Expands Direct Sales Presence Into India 143
10.2 Government and Public Interest 143
10.2.1 Jul 27, 2010: NCKU, NCKU Hospital Cooperate To Develop Rehabilitation Robot 143
10.2.2 Jul 09, 2010: NCKU Brain Mind Welfare Team Developed Responsive Epilepsy Control System 144
10.3 Product News 145
10.3.1 Aug 19, 2010: MUH Performs Australia's First Gamma Knife surgery With Elekta's Leksell Gamma Knife Perfexion System 145
10.3.2 Apr 04, 2010: Study Identifies New Genetic Risk Factors For Brain Aneurysms 146
10.3.3 Mar 31, 2010: Genetic Defect In Schizophrenia Associates With Disruption In Brain Connection 146
10.3.4 Mar 31, 2010: New Preclinical Trial Gives Awareness Of Gene Mutation Causing Parkinson's Disease 148
11 Appendix 149
11.1 Definitions of Markets Covered in the Report 150
11.1.1 Neurology Devices 150
11.2 Research Methodology 151
11.3 Secondary Research 151
11.4 Primary Research 152
11.5 Models 152
11.6 Forecasts 153
11.7 Expert Panels 153
11.8 GlobalData Consulting 153
11.9 Currency Conversion 154
11.10 Contact Us 154
11.11 Disclaimer 154
1.1 List of Tables
Table 1: Neurology Devices, Cross Country Comparison, Revenue ($m), 2003-2017 13
Table 2: Neurology Devices, Asia-Pacific, Overall Revenue ($m), 2003-2017 15
Table 3: Nephrology and Urology Devices, Asia-Pacific, Cross-Category Analysis, 2003-2017 16
Table 4: Neurology Devices, Asia-Pacific, Overall Revenue ($m), Historic, 2003-2010 18
Table 5: Neurology Devices, Asia-Pacific, Overall Revenue ($m), Forecast, 2010-2017 20
Table 6: Neurology Devices, Asia-Pacific, Category Volume (Units), 2003-2017 21
Table 7: Neurology Devices, Asia-Pacific, Category Volume (Units), Historic, 2003-2010 23
Table 8: Neurology Devices, Asia-Pacific, Category Volume (Units), Forecast, 2010-2017 25
Table 9: Neurology Devices, Asia-Pacific, Company share by Revenue ($m), 2009-2010 27
Table 10: Neurology Devices, Japan, Overall Revenue ($m), 2003-2017 29
Table 11: Neurology Devices, Japan, Overall Revenue ($m), Historic, 2003-2010 31
Table 12: Neurology Devices, Japan, Overall Revenue ($m), Forecast, 2010-2017 33
Table 13: Neurology Devices, Japan, Category Volume (Units), 2003-2017 34
Table 14: Neurology Devices, Japan, Category Volume (Units), Historic, 2003-2010 36
Table 15: Neurology Devices, Japan, Category Volume (Units), Forecast, 2010-2017 38
Table 16: CSF Management, Japan, Distribution Share by Revenue ($m), 2009-2010 39
Table 17: Interventional Neurology, Japan, Distribution Share by Revenue ($m), 2009-2010 39
Table 18: Neurological Diagnostic Equipment, Japan, Distribution Share by Revenue ($m), 2009-2010 40
Table 19: Neurostimulation Devices, Japan, Distribution Share by Revenue ($m), 2009-2010 40
Table 20: Neurosurgical Products, Japan, Distribution Share by Revenue ($m), 2009-2010 41
Table 21: Radiosurgery, Japan, Distribution Share by Revenue ($m), 2009-2010 41
Table 22: Neurology Devices, Japan, Company Share by Revenue ($m), 2009-2010 43
Table 23: CSF Management, Japan, Company Share by Revenue ($m), 2009-2010 44
Table 24: Interventional Neurology, Japan, Company Share by Revenue ($m), 2009-2010 46
Table 25: Neurological Diagnostic Equipment, Japan, Company Share by Revenue ($m), 2009-2010 47
Table 26: Neurostimulation Devices, Japan, Company Share by Revenue ($m), 2009-2010 48
Table 27: Neurosurgical Products, Japan, Company Share by Revenue ($m), 2009-2010 49
Table 28: Radiosurgery, Japan, Company Share by Revenue ($m), 2009-2010 50
Table 29: Neurology Devices, Australia, Overall Revenue ($m), 2003-2017 52
Table 30: Neurology Devices, Australia, Overall Revenue ($m), Historic, 2003-2010 54
Table 31: Neurology Devices, Australia, Overall Revenue ($m), Forecast, 2010-2017 56
Table 32: Neurology Devices, Australia, Category Volume (Units), 2003-2017 57
Table 33: Neurology Devices, Australia, Category Volume (Units), Historic, 2003-2010 59
Table 34: Neurology Devices, Australia, Category Volume (Units), Forecast, 2010-2017 61
Table 35: CSF Management, Australia, Distribution Share by Revenue ($m), 2009-2010 62
Table 36: Interventional Neurology, Australia, Distribution Share by Revenue ($m), 2009-2010 62
Table 37: Neurological Diagnostic Equipment, Australia, Distribution Share by Revenue ($m), 2009-2010 63
Table 38: Neurostimulation Devices, Australia, Distribution Share by Revenue ($m), 2009-2010 63
Table 39: Neurosurgical Products, Australia, Distribution Share by Revenue ($m), 2009-2010 64
Table 40: Radiosurgery, Australia, Distribution Share by Revenue ($m), 2010 64
Table 41: Neurology Devices, Australia, Company Share by Revenue ($m), 2009-2010 66
Table 42: CSF Management, Australia, Company Share by Revenue ($m), 2009-2010 68
Table 43: Interventional Neurology, Australia, Company Share by Revenue ($m), 2009-2010 70
Table 44: Neurological Diagnostic Equipment, Australia, Company Share by Revenue ($m), 2009-2010 72
Table 45: Neurostimulation Devices, Australia, Company Share by Revenue ($m), 2009-2010 74
Table 46: Neurosurgical Products, Australia, Company Share by Revenue ($m), 2009-2010 75
Table 47: Radiosurgery, Australia, Company Share by Revenue ($m), 2010 76
Table 48: Neurology Devices, China, Overall Revenue ($m), 2003-2017 78
Table 49: Neurology Devices, China, Overall Revenue ($m), Historic, 2003-2010 80
Table 50: Neurology Devices, China, Overall Revenue ($m), Forecast, 2010-2017 82
Table 51: Neurology Devices, China, Category Volume (Units), 2003-2017 83
Table 52: Neurology Devices, China, Category Volume (Units), Historic, 2003-2010 85
Table 53: Neurology Devices, China, Category Volume (Units), Forecast, 2010-2017 87
Table 54: CSF Management, China, Distribution Share by Revenue ($m), 2009-2010 88
Table 55: Interventional Neurology, China, Distribution Share by Revenue ($m), 2009-2010 88
Table 56: Neurological Diagnostic Equipment, China, Distribution Share by Revenue ($m), 2009-2010 89
Table 57: Neurostimulation Devices, China, Distribution Share by Revenue ($m), 2009-2010 89
Table 58: Neurosurgical Products, China, Distribution Share by Revenue ($m), 2009-2010 90
Table 59: Neurology Devices, China, Company Share by Revenue ($m), 2009-2010 92
Table 60: CSF Management, China, Company Share by Revenue ($m), 2009-2010 94
Table 61: Interventional Neurology, China, Company Share by Revenue ($m), 2009-2010 96
Table 62: Neurological Diagnostic Equipment, China, Company Share by Revenue ($m), 2009-2010 97
Table 63: Neurostimulation Devices, China, Company Share by Revenue ($m), 2009-2010 98
Table 64: Neurosurgical Products, China, Company Share by Revenue ($m), 2009-2010 99
Table 65: Neurology Devices, India, Overall Revenue ($m), 2003-2017 101
Table 66: Neurology Devices, India, Overall Revenue ($m), Historic, 2003-2010 103
Table 67: Neurology Devices, India, Overall Revenue ($m), Forecast, 2010-2017 105
Table 68: Neurology Devices, India, Category Volume (Units), 2003-2017 106
Table 69: Neurology Devices, India, Category Volume (Units), Historic, 2003-2010 108
Table 70: Neurology Devices, India, Category Volume (Units), Forecast, 2010-2017 110
Table 71: CSF Management, India, Distribution Share by Revenue ($m), 2009-2010 111
Table 72: Interventional Neurology, India, Distribution Share by Revenue ($m), 2009-2010 111
Table 73: Neurological Diagnostic Equipment, India, Distribution Share by Revenue ($m), 2009-2010 112
Table 74: Neurostimulation Devices, India, Distribution Share by Revenue ($m), 2009-2010 112
Table 75: Neurosurgical Products, India, Distribution Share by Revenue ($m), 2009-2010 113
Table 76: Radiosurgery, India, Distribution Share by Revenue ($m), 2009-2010 113
Table 77: Neurology Devices, India, Company Share by Revenue ($m), 2009-2010 115
Table 78: CSF Management, India, Company Share by Revenue ($m), 2009-2010 116
Table 79: Interventional Neurology, India, Company Share by Revenue ($m), 2009-2010 118
Table 80: Neurological Diagnostic Equipment, India, Company Share by Revenue ($m), 2009-2010 119
Table 81: Neurostimulation Devices, India, Company Share by Revenue ($m), 2009-2010 120
Table 82: Neurosurgical Products, India, Company Share by Revenue ($m), 2009-2010 122
Table 83: Radiosurgery, India, Company Share by Revenue ($m), 2009-2010 123
Table 84: Neurology Devices Market Pipeline Products 137
Table 85: USD to Local Currency, Asia-Pacific, Average Exchange Rate 2003-2010 155
1.2 List of Figures
Figure 1: Neurology Devices, Cross Country Comparison Revenue ($m), 2003-2017 13
Figure 2: Neurology Devices, Asia-Pacific, Overall Revenue ($m), 2003-2017 14
Figure 3: Neurology Devices, Asia-Pacific, Cross-Category Analysis, 2003-2017 16
Figure 4: Neurology Devices, Asia-Pacific, Overall Revenue ($m), Historic, 2003-2010 17
Figure 5: Neurology Devices, Asia-Pacific, Overall Revenue ($m), Forecast, 2010-2017 19
Figure 6: Neurology Devices, Asia-Pacific, Category Volume (Units), 2003-2017 21
Figure 7: Neurology Devices, Asia-Pacific, Category Volume (Units), Historic, 2003-2010 22
Figure 8: Neurology Devices, Asia-Pacific, Category Volume (Units), Forecast, 2010-2017 24
Figure 9: Neurology Devices, Asia-Pacific, Company share (%), 2010 26
Figure 10: Neurology Devices, Japan, Overall Revenue ($m), 2003-2017 28
Figure 11: Neurology Devices, Japan, Overall Revenue ($m), Historic, 2003-2010 30
Figure 12: Neurology Devices, Japan, Overall Revenue ($m), Forecast, 2010-2017 32
Figure 13: Neurology Devices, Japan, Category Volume (Units), 2003-2017 34
Figure 14: Neurology Devices, Japan, Category Volume (Units), Historic, 2003-2010 35
Figure 15: Neurology Devices, Japan, Category Volume (Units), Forecast, 2010-2017 37
Figure 16: Neurology Devices, Japan, Company Share (%), 2010 42
Figure 17: CSF Management, Japan, Company Share (%), 2010 44
Figure 18: Interventional Neurology, Japan, Company Share (%), 2010 45
Figure 19: Neurological Diagnostic Equipment, Japan, Company Share (%), 2010 47
Figure 20: Neurostimulation Devices, Japan, Company Share (%), 2010 48
Figure 21: Neurosurgical Products, Japan, Company Share (%), 2010 49
Figure 22: Radiosurgery, Japan, Company Share (%), 2010 50
Figure 23: Neurology Devices, Australia, Overall Revenue ($m), 2003-2017 51
Figure 24: Neurology Devices, Australia, Overall Revenue ($m), Historic, 2003-2010 53
Figure 25: Neurology Devices, Australia, Overall Revenue ($m), Forecast, 2010-2017 55
Figure 26: Neurology Devices, Australia, Category Volume (Units), 2003-2017 57
Figure 27: Neurology Devices, Australia, Category Volume (Units), Historic, 2003-2010 58
Figure 28: Neurology Devices, Australia, Category Volume (Units), Forecast, 2010-2017 60
Figure 29: Neurology Devices, Australia, Company Share (%), 2010 65
Figure 30: CSF Management, Australia, Company Share (%), 2010 67
Figure 31: Interventional Neurology, Australia, Company Share (%), 2010 69
Figure 32: Neurological Diagnostic Equipment, Australia, Company Share (%), 2010 71
Figure 33: Neurostimulation Devices, Australia, Company Share (%), 2010 73
Figure 34: Neurosurgical Products, Australia, Company Share (%), 2010 75
Figure 35: Neurology Devices, China, Overall Revenue ($m), 2003-2017 77
Figure 36: Neurology Devices, China, Overall Revenue ($m), Historic, 2003-2010 79
Figure 37: Neurology Devices, China, Overall Revenue ($m), Forecast, 2010-2017 81
Figure 38: Neurology Devices, China, Category Volume (Units), 2003-2017 83
Figure 39: Neurology Devices, China, Category Volume (Units), Historic, 2003-2010 84
Figure 40: Neurology Devices, China, Category Volume (Units), Forecast, 2010-2017 86
Figure 41: Neurology Devices, China, Company Share (%), 2010 91
Figure 42: CSF Management, China, Company Share (%), 2010 93
Figure 43: Interventional Neurology, China, Company Share (%), 2010 95
Figure 44: Neurological Diagnostic Equipment, China, Company Share (%), 2010 97
Figure 45: Neurostimulation Devices, China, Company Share (%), 2010 98
Figure 46: Neurosurgical Products, China, Company Share (%), 2010 99
Figure 47: Neurology Devices, India, Overall Revenue ($m), 2003-2017 100
Figure 48: Neurology Devices, India, Overall Revenue ($m), Historic, 2003-2010 102
Figure 49: Neurology Devices, India, Overall Revenue ($m), Forecast, 2010-2017 104
Figure 50: Neurology Devices, India, Category Volume (Units), 2003-2017 106
Figure 51: Neurology Devices, India, Category Volume (Units), Historic, 2003-2010 107
Figure 52: Neurology Devices, India, Category Volume (Units), Forecast, 2010-2017 109
Figure 53: Neurology Devices, India, Company Share (%), 2010 114
Figure 54: CSF Management, India, Company Share (%), 2010 116
Figure 55: Interventional Neurology, India, Company Share (%), 2010 117
Figure 56: Neurological Diagnostic Equipment, India, Company Share (%), 2010 119
Figure 57: Neurostimulation Devices, India, Company Share (%), 2010 120
Figure 58: Neurosurgical Products, India, Company Share (%), 2010 121
Figure 59: Medtronic, Inc., Company Share (%), Asia-Pacific Neurology Devices Market, 2010 124
Figure 60: Terumo Corporation, Company Share (%), Asia-Pacific Neurology Devices Market, 2010 125
Figure 61: Boston Scientific Corporation, Company Share (%), Asia-Pacific Neurology Devices Market, 2010 126
Figure 62: Nihon Kohden Corporation, Company Share (%), Asia-Pacific Neurology Devices Market, 2010 128
Figure 63: Elekta AB, Company Share (%), Asia-Pacific Neurology Devices Market, 2010 129
Figure 64: DePuy, Inc., Company Share (%), Asia-Pacific Neurology Devices Market, 2010 130Medtronic, Inc.
Terumo Corporation
Boston Scientific Corporation
Nihon Kohden Corporation
Elekta AB
DePuy, Inc.
St. Jude Medical, Inc.
Covidien plc
B. Braun Melsungen AG
Micrus Endovascular Corporation
Integra LifeSciences Holdings Corporation
Cadwell Laboratories, Inc.
ev3 Inc.
CareFusion Corporation
Accuray Incorporated
Cyberonics, Inc.
Mizuho Ikakogyo Co., Ltd.
Natus Medical Incorporated
Sophysa S.A.
KARL STORZ GmbH & Co. KG
Micromed S.p.A
To order this report:
: Asia-Pacific Neurology Devices Market Outlook to 2017
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article